We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Dmitry Velmeshev, PhD

Dmitry Velmeshev, PhD

Contact Us

Dr. Dmitry Velmeshev is a postdoctoral research fellow at the University of California, San Francisco. Velmeshev received his PhD from the University of Miami, where he studied molecular mechanisms of autism spectrum disorder. He then joined the laboratory of Dr. Arnold Kriegstein at UCSF. His research focuses on applying single-cell genomics and bioinformatics techniques to understand how specific cell types change during human brain development and in disease, especially neurodevelopmental disorders.


Latest Content
How To Optimize Next-Generation Sequencing Workflows
How To Guide

How To Optimize Next-Generation Sequencing Workflows

Download this guide to learn more about techniques such as bulk tissue RNA sequencing, single-nucleus RNA sequencing and whole-genome DNA sequencing.
5 Specialized Techniques for Fragment-based Drug Discovery
Listicle

5 Specialized Techniques for Fragment-based Drug Discovery

In this list, we will discuss the principles of FBDD, how it compares to other drug discovery approaches, as well as highlighting various techniques that allow for lead compound identification with FBDD.
Recent Advances and Applications of Single-Cell Sequencing
Article

Recent Advances and Applications of Single-Cell Sequencing

Here, we review the most commonly adopted technologies and workflows available for single-cell sequencing and discuss current research studies adopting such approaches.
Recent Advances in Single-cell Genomics Techniques
Article

Recent Advances in Single-cell Genomics Techniques

Single-cell genomics methods, such as single cell RNA sequencing (scRNA-seq), involve labeling biomolecules originating from individual cells, therefore enabling high-throughput molecular analysis at single-cell resolution. This article explores the recent advances in single-cell genomics techniques, and the applications of such technologies.
Whole-Exome Sequencing at the Dawn of Personalized Medicine
Article

Whole-Exome Sequencing at the Dawn of Personalized Medicine

Deciphering the first complete sequence of the human genome in 2003 required a combined effort of scientists from 20 institutions and $3 billion of funding. Over the last decade, whole-exome sequencing (WES) established itself as a method that successfully balances cost and the output of useful data for diagnostic or research applications. Here, we look at how WES is used in both the laboratory and the clinic, and why it is a preferred method of choice in such areas.
Advertisement